Immunologic Deficiency Syndromes  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT02761629: Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus

Completed
4
180
RoW
Peg-Interferon Alpha-2A, Pegasys, Peg-IFN-Alpha-2A, Ribavirin
Hoffmann-La Roche
Hepatitis C, Chronic
05/08
05/08
NCT00353418 / 2005-005506-23: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Completed
4
415
US
Peginterferon alfa-2a, Pegasys, Ribavirin, Copegus
Hoffmann-La Roche
Hepatitis C, Chronic
04/09
04/09
SAEI_IFN_1, NCT00553930 / 2007-000814-35: Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Completed
4
71
Europe
Pegylated interferon alfa-2a and Ribavirin, Pegasys, Copegus, Pegylated interferon alfa 2a and Ribavirin, Pegasis (TM), Copegus (TM)
Sociedad Andaluza de Enfermedades Infecciosas
Hepatitis C, Chronic, HIV Infections
05/10
05/10
NCT00132210: Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients

Completed
4
200
Europe
pegylated interferon, Pegasys, PegIntron, Copegus, Rebetol
University Hospital, Bonn
Hepatitis C, HIV Infections
06/10
06/10
CONTRA, NCT01684787: Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

Completed
4
80
Europe
Peginterferon alfa-2a + ribavirin in normal ALT, Pegasys + ribavirin, Peginterferon alfa-2a + ribavirin in elevated ALT
Miguel Santin
Chronic Hepatitis C
05/11
06/11

Download Options